The B12 supplementation market is experiencing unprecedented growth, driven by three converging mega-trends: the rise of plant-based diets, consumer demand for sustainable solutions, and breakthroughs in precision fermentation technology.
Market Dynamics
The global B12 supplement market reached $4.2B in 2025 and is projected to exceed $8B by 2030, representing a compound annual growth rate (CAGR) of 12%+. This growth outpaces the broader supplement category by 3-4x.
Key Growth Drivers
Plant-Based Adoption: With over 39% of consumers identifying as plant-based or flexitarian, the demand for plant-derived B12 alternatives has surged. Traditional cyanocobalamin supplements face increasing skepticism, creating a market opportunity for bioavailable, plant-sourced alternatives.
Precision Fermentation: Companies leveraging fermentation technology can now produce bioavailable B12 at scale, reducing manufacturing costs by 40-60% while improving sustainability metrics. This unlocks premium pricing power for brands positioning around sustainability and efficacy.
Clinical Validation: Emerging research links optimized B12 supplementation to cognitive support, cellular energy, and age-related wellness—creating clinical differentiation and premium positioning opportunities.
Investment Implications
The companies best positioned to capture this opportunity share three characteristics:
- Proprietary Technology: Whether fermentation platforms, bioavailability optimization, or supply chain innovation
- Clinical Evidence: Published data supporting efficacy claims and premium positioning
- Scalable Business Models: Direct-to-consumer, professional channels, or CPG partnerships enabling rapid growth
We’re actively seeking Series A and growth-stage investments in this space. Companies with $5M+ revenue, 50%+ YoY growth, and differentiated products are ideal candidates.
What’s Next
The next 24 months will be critical for market consolidation. Major CPG and pharma players are building or acquiring B12 platforms. Companies that secure institutional capital and execute disciplined go-to-market strategies will command 3-5x exits within 5-7 years.
The B12 revolution is just beginning.